CD47 and neoplasm: Tumor cells exploit similar evasion strategies by overexpressing these inhibitory signals (e.g., CD47, CD24) or reprogramming macrophages toward pro-tumoral phenotypes via tumor microenvironment (TME) remodeling [355–357].